What is Phio Pharmaceuticals Corp. (PHIO) Stock Return on Shareholders’ Capital?

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) stock fell -2.30% on Wednesday to $4.24 against a previous-day closing price of $4.34. With 1.41 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.58 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $5.2900 whereas the lowest price it dropped to was $4.0500. The 52-week range on PHIO shows that it touched its highest point at $12.27 and its lowest point at $3.11 during that stretch. It currently has a 1-year price target of $72.00. Beta for the stock currently stands at 1.44.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PHIO was up-trending over the past week, with a rise of 12.77%, but this was up by 26.57% over a month. Three-month performance dropped to -17.99% while six-month performance fell -14.61%. The stock lost -48.12% in the past year, while it has lost -5.02% so far this year.

Float and Shares Shorts:

At present, 1.14 million PHIO shares are outstanding with a float of 1.13 million shares on hand for trading. On Apr 27, 2023, short shares totaled 29880.0, which was 1.99% higher than short shares on Mar 30, 2023. In addition to Mr. Robert J. Bitterman as the firm’s Pres, CEO & Chairman, Ms. Caitlin Kontulis serves as its VP of Fin. & Admin. and Sec.

Institutional Ownership:

Through their ownership of 3.19% of PHIO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.10% of PHIO, in contrast to 1.74% held by mutual funds. Shares owned by individuals account for 1.66%. As the largest shareholder in PHIO with 1.24% of the stake, Renaissance Technologies LLC holds 14,280 shares worth 14,280. A second-largest stockholder of PHIO, Cambridge Investment Research Adv, holds 14,233 shares, controlling over 1.24% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in PHIO, holding 10,277 shares or 0.89% stake. With a 0.89% stake in PHIO, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 10,277 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.48% of PHIO stock, is the second-largest Mutual Fund holder. It holds 5,511 shares valued at 18627.0. Fidelity Nasdaq Composite Index F holds 0.25% of the stake in PHIO, owning 2,856 shares worth 9653.0.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, PHIO reported revenue of $0.00 and operating income of -$2.52M. The EBITDA in the recently reported quarter was -$2.50M and diluted EPS was -$2.28.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PHIO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PHIO analysts setting a high price target of $72.00 and a low target of $72.00, the average target price over the next 12 months is $72.00. Based on these targets, PHIO could surge 1598.11% to reach the target high and rise by 1598.11% to reach the target low. Reaching the average price target will result in a growth of 1598.11% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded PHIO stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 335 shares were sold. The number of buy transactions has increased to 16 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 98,715 while 992 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *